Cryogenic containers which use liquid nitrogen are set to play an important role in the storage and distribution of coronavirus (Covid-19) vaccines.
Manufacturers of the products, which will keep vaccines at ultra-cold temperatures, claim cryogenic containers hold an advantage over storing vaccines with dry ice due to the longevity they offer.
Cryoport, a provider of cold chain logistics solutions with headquarters in Brentwood, Tennessee, recently acquired MVE Biological Solutions (MVE) from Chart Industries and CRYOPDP to increase its capabilities to ship materials at low temperatures.
... to continue reading you must be subscribed
